Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent...
4 KB (351 words) - 04:12, 25 September 2024
offered to acquire Ablynx for $3.1 billion - having made an unreported offer in mid-December for the company. However, the Ablynx board rejected this...
39 KB (3,672 words) - 17:34, 25 September 2024
diseases. Ozoralizumab was developed by Pfizer Inc, and now belongs to Ablynx NV. Ablynx has licensed the rights to the antibody in China to Eddingpharm. In...
3 KB (128 words) - 20:00, 20 December 2023
20 listings, with the exception a one-month period in May–June 2018 when Ablynx stock was removed following the takeover by Sanofi, only to be replaced...
16 KB (586 words) - 19:01, 24 August 2024
thrombocytopenic purpura (TTP) and thrombosis. This drug was developed by Ablynx NV. On 30 August 2018, it was approved in the European Union for the "treatment...
9 KB (660 words) - 15:28, 4 August 2024
Bioverativ for $11.6 billion and days later announced that it would acquire Ablynx for €3.9 billion ($4.8 billion). In December 2019, the company announced...
92 KB (8,810 words) - 04:11, 13 September 2024
Global 500". Fortune. "Llama-Based Biotechnology Draws New Interest to Ablynx". Bloomberg. 2015-05-13. Retrieved 2017-12-20. "Alpro - About Alpro". www...
22 KB (551 words) - 09:52, 12 June 2024
The Ghent University and several research-oriented companies, such as Ablynx, Innogenetics, Cropdesign, and Bayer Cropscience, are situated in the central...
53 KB (4,943 words) - 08:02, 28 September 2024
risk percutaneous coronary intervention has started in September 2009. Ablynx expects that their Nanobodies might cross the blood–brain barrier and permeate...
35 KB (3,898 words) - 14:53, 18 May 2024
per share in cash or about $9.5 billion in total. In July 2015, Merck and Ablynx expanded their 18-month-old immuno-oncology collaboration by four years...
97 KB (9,573 words) - 19:27, 23 September 2024
treatment of inflammatory autoimmune diseases. This drug was developed by Ablynx NV to block interleukin-6 receptor. Vobarilizumab has been evaluated in...
3 KB (213 words) - 01:47, 29 October 2023
in the creation of spin-offs from academic research groups, such as for Ablynx, DevGen, CropDesign, ActoGeniX, Pronota (formerly Peakadilly), Agrosavfe...
8 KB (693 words) - 23:47, 26 August 2024
rare blood clotting disorders) reached the market in February 2019 (www.ablynx.com). Meanwhile, IP limitations on VHHs are diminishing and more biotechnology...
30 KB (3,084 words) - 04:39, 12 August 2024
director of DevGen and CropDesign and is a director of the biotech companies Ablynx, Peakadilly, Actogenix, EMBLEM (technology transfer company of EMBL) and...
2 KB (184 words) - 01:45, 3 June 2023
Biotechnologie (VIB). He was involved in the foundation of three spin-off companies: Ablynx, Biotalys, and Confo Therapeutics. Steyaert was born in Ukkel, Belgium....
15 KB (1,476 words) - 18:59, 14 August 2024
single-domain antibodies or nanobodies. Flanders Institute for Biotechnology (VIB) Ablynx "(Dutch) Prof. Em. Raymond Hamers, ontdekker nanobodies, overleden". Medi-Sfeer...
2 KB (151 words) - 01:05, 12 January 2023